Skip to content
10-K

Annual Report

NUTRA PHARMA CORP. NPHC

0001493152-26-007044

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 17, 2026 7.16B sh
Short Term Debt FY 2024 · Dec 31, 2024 $8.49M
Sga Expense FY 2024 · Dec 31, 2024 $1.13M
Sga Expense FY 2024 · Dec 31, 2023 $1.18M
Shares Diluted FY 2024 · Dec 31, 2023 7.61B sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$550.04K
Long Term Debt FY 2024 · Dec 31, 2023 $143.66K
Short Term Investments FY 2024 · Dec 31, 2023 $35.2K
Cash And Equivalents FY 2024 · Dec 31, 2023 $0
Current Liabilities FY 2024 · Dec 31, 2023 $14.17M
Total Liabilities FY 2024 · Dec 31, 2023 $14.41M
Current Assets FY 2024 · Dec 31, 2023 $314.06K
Total Assets FY 2024 · Dec 31, 2023 $640.4K
Eps Diluted FY 2024 · Dec 31, 2023 $0.00
Eps Basic FY 2024 · Dec 31, 2023 $0.00
Net Income FY 2024 · Dec 31, 2023 −$1.39M
Operating Income FY 2024 · Dec 31, 2023 −$886.98K
Gross Profit FY 2024 · Dec 31, 2023 $396.46K
Revenue FY 2024 · Dec 31, 2023 $205.56K
Stockholders Equity FY 2024 · Dec 31, 2022 −$12.38M